These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 25392158)
1. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center. Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158 [TBL] [Abstract][Full Text] [Related]
2. HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA. Cheng Kiat Ng L; Shwei Wen Tham C; Wei Inng Lim F; Chen Y; Yeu Ong S; Nagarajan C; Lee JJ; Tee Goh Y; Linn YC; Shan Lee Y; Diong Phipps C; Kim Siang Quek J; Hein T; Cheng Hwang JC; Grigoropoulos N; Khee Hwang WY; Yew Leng Ho A Blood Cell Ther; 2021 Nov; 4(4):92-100. PubMed ID: 36714065 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis. Wei J; Xu J; Cao Y; Zhou J; Zhang Y Acta Haematol; 2015; 133(2):136-44. PubMed ID: 25247746 [TBL] [Abstract][Full Text] [Related]
4. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation. Gkotzamanidou M; Papadimitriou CA Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation. Jeong SH; Song HN; Park JS; Yang DH; Koh Y; Yoon SS; Lee HW; Eom HS; Won JH; Kim WS; Kim SJ Biol Blood Marrow Transplant; 2018 Dec; 24(12):2471-2478. PubMed ID: 30064012 [TBL] [Abstract][Full Text] [Related]
6. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC. Tessoulin B; Ceballos P; Chevallier P; Blaise D; Tournilhac O; Gauthier J; Maillard N; Tabrizi R; Choquet S; Carras S; Ifrah N; Guillerm G; Mohty M; Tilly H; Socie G; Cornillon J; Hermine O; Daguindau É; Bachy E; Girault S; Marchand T; Oberic L; Reman O; Leux C; Le Gouill S Bone Marrow Transplant; 2016 Sep; 51(9):1184-90. PubMed ID: 27111043 [TBL] [Abstract][Full Text] [Related]
9. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658 [TBL] [Abstract][Full Text] [Related]
10. The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience. Rohlfing S; Dietrich S; Witzens-Harig M; Hegenbart U; Schönland S; Luft T; Ho AD; Dreger P Ann Hematol; 2018 Jul; 97(7):1241-1250. PubMed ID: 29549411 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation. Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380 [TBL] [Abstract][Full Text] [Related]
12. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation. Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect. Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377 [TBL] [Abstract][Full Text] [Related]
14. Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method. Gutiérrez-Aguirre CH; Ruiz-Argüelles G; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; García-Rodríguez F; López-Otero A; Herrera-Garza JL; Gómez-Almaguer D Ann Hematol; 2010 Oct; 89(10):1045-52. PubMed ID: 20490794 [TBL] [Abstract][Full Text] [Related]
15. Impact of New Drugs on the Long-Term Follow-Up of Upfront Tandem Autograft-Allograft in Multiple Myeloma. Giaccone L; Evangelista A; Patriarca F; Sorasio R; Pini M; Carnevale-Schianca F; Festuccia M; Brunello L; Zallio F; Maffini E; Omedé P; Bringhen S; Mordini N; Fanin R; Ciccone G; Boccadoro M; Bruno B Biol Blood Marrow Transplant; 2018 Jan; 24(1):189-193. PubMed ID: 28987930 [TBL] [Abstract][Full Text] [Related]
16. Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma. Crocchiolo R; Castagna L; Fürst S; El-Cheikh J; Faucher C; Oudin C; Granata A; Bouabdallah R; Coso D; Chabannon C; Balzarotti M; Santoro A; Blaise D Bone Marrow Transplant; 2013 Feb; 48(2):249-52. PubMed ID: 22732704 [TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A; Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922 [TBL] [Abstract][Full Text] [Related]
18. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China. Gu ZY; Dong YJ; Fu XR; Li NN; Liu Y; Wu XX; Wang YN; Li YH; Ren HY; Zhang MZ; Li XF; Wang MH; Wu YM; Liu DH; Wang Z; Hu LD; Huang WR Chin Med J (Engl); 2021 Jun; 134(13):1584-1592. PubMed ID: 34133361 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of allogeneic or autologous hematopoietic stem cell transplant for high-risk peripheral T cell lymphomas]. Wang QL; Huang HW; Jin ZM; Tang XW; Qiu HY; Fu CC; Han Y; Miao M; Chang HR; Sun AN; Wu DP Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):952-956. PubMed ID: 27995879 [TBL] [Abstract][Full Text] [Related]
20. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas. Shustov A Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]